当前位置: 首页 > 期刊 > 《中国实用医药》 > 2008年第12期
编号:11605795
血清PON1活性与冠状动脉粥样硬化研究新进展(3)
http://www.100md.com 2008年6月22日 《中国实用医药》 2008年第12期
     12 ROZENBERGO,SHINDM,AVIRAMM.Human serum paraoxonase1 (PON1)dreases macrophage cholesterol biosynthesis:a possible role for its phosphor-lipase-A2 ativity andlysophosphatidylcholineformation.Arterioscler Thromb Vasc Biol,2003,23:461-467。

    13 Beltowski J , Wojcicka G, Jamroz A. Effect of 3-hydroxy-3-methylglutarylc -oenzyme A reductase inhibitors ( statins) on tissue paraoxonase 1 and plasma platelet activating factor acetylhydrolase activities. Cardiovasc Pharmacol ,2004,43(1):121-127.

    14 Deakin S,Leviev I,Guernier S,James RW.Simvastatinmodulates expression Of the PON1 gene and increases serum paraoxonase:arole for sterol regulatory element 2binding protein22. Arterioscler Thromb Vasc Biol,2003,23 ( 11 ) : 2083-2089.

    15 ROSENBI AT M ,H AYEK T,H USSEIN K,eta1.Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholestero1 content:effect of atorvastatln therapy.Arterioscler Thromb Vasc Bio1,2004,24:175-180.

    16 Bin Ali A,Zhang Q,Lim YK,et a1.Expression of major HDL-associated antioxidant PON-l is gender dependent an d regulated during inflaHmtion. Free Radic Biol Med,2003,34(7):824-829.

    17 Serhatlioglu S , Gursu MF , Gulcu F , Canatan H , Godekmerdan A. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation. Cell Biochem Funct,2003,21(4) : 371-375., http://www.100md.com(曾宪钦 胡雪松)
上一页1 2 3